POTS Natural Treatment: Evidence-Based Protocol [2026]

The most effective non-pharmacological treatments for POTS are salt and fluid loading (3-10g sodium daily, 2021 Expert Consensus), graded recumbent exercise (the CHOP and Dallas protocols produced remission in 53% of participants at 3 months), and electrolyte optimization with magnesium, potassium, and sodium in combination. POTS affects an estimated 1 to 3 million Americans, and cases have surged since the pandemic. As many as 80% of long-COVID patients meet POTS diagnostic criteria. No medication is FDA-approved for POTS. Natural interventions address the root mechanisms that off-label pharmaceuticals do not: blood volume deficit, cardiac deconditioning, and autonomic tone. Discuss all protocols with your cardiologist or autonomic specialist before starting.

Understanding POTS and Why Natural Treatments Matter

Postural orthostatic tachycardia syndrome is defined by a heart rate increase of 30 beats per minute or more (40 bpm in adolescents) within 10 minutes of standing, without a corresponding drop in blood pressure. The diagnosis is confirmed via tilt table test or active standing test. The symptoms go well beyond a fast heartbeat: brain fog, exercise intolerance, nausea, tremor, and fatigue that can be disabling.

POTS is not a single disease. It has at least three recognized subtypes, and treatments differ meaningfully between them.

Neuropathic POTS involves damage to the small nerve fibers that regulate blood vessel constriction in the legs. Blood pools because the vessels fail to tighten on standing. This is the most common subtype and responds well to compression, exercise, and salt loading.

Hyperadrenergic POTS features excessive norepinephrine release on standing. Heart rate and blood pressure both spike. These patients often feel wired and anxious rather than faint. Salt loading must be approached cautiously here because blood pressure may already be elevated.

Hypovolemic POTS involves reduced total blood volume, sometimes by 13-20% below normal. These patients benefit most aggressively from salt and fluid loading, which directly corrects the underlying deficit.

Conventional treatment relies on off-label medications: fludrocortisone to expand blood volume, midodrine to constrict blood vessels, and beta-blockers to slow heart rate. None of these are FDA-approved for POTS. None address deconditioning, autonomic tone, or the immune dysregulation that drives many cases. Natural interventions fill these gaps directly.

The Autoimmune POTS Connection

A growing body of evidence demonstrates that POTS is frequently autoimmune in origin. Understanding this connection changes how you approach treatment.

Antibodies Against the Autonomic Nervous System

Researchers led by Fedorowski and colleagues identified autoantibodies against G-protein coupled receptors in POTS patients, specifically anti-adrenergic and anti-muscarinic receptor antibodies. These antibodies interfere with the autonomic signaling that regulates heart rate and blood vessel tone. When the immune system attacks the receptors that control your cardiovascular response to gravity, the result is exactly what POTS looks like.

Autoimmune POTS frequently overlaps with other autoimmune conditions. Hashimoto's thyroiditis, Sjogren's syndrome, and lupus all appear at elevated rates in POTS populations. Ehlers-Danlos syndrome and mast cell activation syndrome (MCAS) form another common triad with POTS. If you have one autoimmune condition, screening for autoimmune disease symptoms across multiple systems is worthwhile.

Post-COVID POTS: The Surge

The pandemic created a new generation of POTS patients. Studies published in Nature Reviews Cardiology (2023) and Oxford Open Immunology (2023) documented that approximately 80% of long-COVID patients meet POTS diagnostic criteria. The mechanisms include molecular mimicry (viral proteins resembling autonomic receptor proteins), direct vagal nerve injury from SARS-CoV-2, and persistent neuroinflammation.

Post-COVID POTS has distinct immunological features. Patients often show elevated inflammatory markers, autoantibody formation, and immune activation patterns that differ from classical deconditioning-related POTS. This matters because autoimmune and post-COVID POTS may respond to immunomodulatory strategies (LDN, vagal nerve stimulation) that would not help someone whose POTS stems purely from prolonged bedrest.

How We Grade the Evidence

Every intervention in this guide receives an evidence grade:

• Grade A: Multiple randomized controlled trials or meta-analyses, or expert consensus guidelines
• Grade B: Single RCT, multiple case series, or strong mechanistic plus clinical evidence
• Grade C: Preliminary, mechanistic, or animal evidence only

POTS research is younger than research for conditions like rheumatoid arthritis or Hashimoto's. Some interventions with Grade A ratings earned them through expert consensus statements backed by substantial clinical experience rather than large multi-center RCTs. We note when this is the case.

Salt and Fluid Loading [Grade A]

Salt loading is the single most universally recommended intervention for POTS. The 2021 POTS Expert Consensus Review endorses 2 to 3 liters of fluid daily combined with 3 to 10 grams of sodium per day. For context, the standard dietary recommendation is 2.3 grams.

The Evidence

An RCT examining high versus low sodium diets in POTS patients found that high sodium intake decreased upright heart rate, corrected the plasma volume deficit characteristic of hypovolemic POTS, and reduced circulating norepinephrine. The mechanism is direct: sodium expands plasma volume, which increases venous return to the heart, which reduces the compensatory tachycardia that defines the syndrome. (PMC 8103825)

The Expert Consensus goes further than any single trial. It synthesizes decades of clinical experience from POTS specialists worldwide, and salt/fluid loading is the intervention with the broadest agreement across all POTS subtypes (with appropriate caution in hyperadrenergic patients).

Protocol

Starting dose: 3g sodium daily, spread across meals and supplements. Track intake for the first two weeks until you develop intuition for quantities.

Titration: Increase by 1-2g per week based on symptom response. Most patients stabilize between 5 and 8g daily. The upper end of 10g is reserved for severe hypovolemic cases under medical supervision.

Practical strategies: Salt tablets (Vitassium and SaltStick are the most commonly used in the POTS community) provide measured doses. Salting food liberally, drinking bone broth, and adding electrolyte drinks round out daily intake.

Fluid target: 2 to 3 liters daily, with the key caveat that plain water alone is insufficient. Water without electrolytes dilutes serum sodium and can worsen symptoms. Always pair fluid with sodium.

Monitoring: Check blood pressure regularly. Patients with hyperadrenergic POTS or any history of hypertension should start at the lower end and increase slowly. Heart failure patients should not increase sodium without cardiology guidance.

Graded Exercise: CHOP, Dallas, and Levine Protocols [Grade A]

Structured exercise is not simply "being more active." The specific protocol matters enormously. Jumping into upright exercise too early is the most common mistake POTS patients make, and it reliably causes symptom worsening that discourages further attempts.

The Evidence

The landmark study was published by Levine and colleagues in the Journal of the American College of Cardiology (2010). After a 3-month structured exercise program, 53% of participants no longer met POTS diagnostic criteria. Cardiac mass increased. Blood volume expanded. Autonomic regulation improved. These were not marginal gains. More than half of participants achieved functional remission.

The CHOP protocol (Children's Hospital of Philadelphia) adapted the Levine/Dallas approach for adolescents and more severely deconditioned patients. It uses a more gradual ramp-up and is now widely used by adult patients as well. Both protocols share the same core principle: start completely recumbent and earn the right to stand. (Boris & Bernadzikowski, CHOP modified Dallas protocol)

A comprehensive review in PMC 6289756 confirmed that exercise-based rehabilitation consistently improves heart rate response, exercise capacity, and quality of life in POTS, making it one of only two interventions (alongside salt loading) with Grade A evidence.

The Three-Phase Approach

Weeks 1-4: Recumbent only. Rowing machine, recumbent bike, or swimming. These exercise modes eliminate the gravitational challenge that triggers POTS symptoms, allowing you to build cardiovascular fitness without provoking crashes. Three to four sessions per week, 25 to 30 minutes each. Keep heart rate in the low aerobic zone (roughly 50-60% of maximum).

Weeks 5-8: Increased volume and intensity. Extend sessions to 35-45 minutes. Increase to four to five sessions per week. Add strength training (bodyweight or light resistance) two sessions weekly. Strength training improves the skeletal muscle pump that pushes venous blood back to the heart.

Weeks 9-12: Introduce upright exercise. Gradually add walking, elliptical, or upright cycling. Start with 10-minute upright segments within a longer recumbent session. Extend upright duration as tolerated.

Critical Mistakes to Avoid

Pushing through post-exertional symptom worsening is counterproductive. If a session triggers a crash, reduce intensity and duration the following session rather than forcing through. The exercise should ideally be supervised initially, particularly for patients with severe deconditioning or those who have experienced syncope.

Electrolyte Optimization [Grade B]

Sodium alone tells only part of the story. Potassium, magnesium, and calcium work together to regulate fluid balance, vascular tone, and cardiac rhythm. POTS patients who optimize sodium but neglect the other electrolytes frequently report incomplete symptom relief.

The Evidence

Patient-reported outcomes and clinical experience from POTS specialty centers consistently show that balanced electrolyte supplementation outperforms sodium supplementation alone. The mechanistic rationale is strong: potassium maintains cellular fluid balance across membranes, magnesium regulates vascular smooth muscle tone, and calcium supports cardiac contractility. Disruption in any of these amplifies the cardiovascular instability of POTS.

Protocol

Sodium: 3-10g daily (see salt loading section above).

Potassium: 4.7g daily, primarily from food sources (avocados, bananas, potatoes, coconut water). Supplemental potassium beyond 99mg per dose requires medical supervision due to cardiac rhythm risks.

Magnesium: 400-800mg daily (see dedicated magnesium section below).

Calcium: Ensure adequate intake through food; supplement only if dietary intake is consistently below 1,000mg daily.

Products: Electrolyte drinks like LMNT, Liquid IV, Vitassium, and Nuun provide balanced ratios. Rotate between brands to vary the mineral profile.

Magnesium [Grade B]

Magnesium deserves its own section because deficiency is common in POTS and the mineral addresses multiple pathways simultaneously.

The Evidence

Magnesium slows rapid heart rate through its role as a natural calcium channel antagonist. It supports vascular smooth muscle relaxation, which improves blood vessel tone. It reduces the exaggerated sympathetic nervous system activation that characterizes hyperadrenergic POTS. And magnesium deficiency, which is widespread in the general population, is especially prevalent in POTS patients due to increased urinary losses from high fluid intake.

No POTS-specific RCT has isolated magnesium supplementation. The Grade B rating reflects the convergence of established cardiovascular physiology, documented deficiency in this population, and consistent clinical improvement reported by POTS specialists.

Protocol

Starting dose: 125mg twice daily. Increase gradually over two to three weeks to 250-500mg twice daily.

Forms: Magnesium glycinate or citrate are preferred. Glycinate is better tolerated gastrointestinally. Avoid magnesium oxide, which has poor absorption and commonly causes diarrhea.

Timing: Divide doses between morning and evening. Evening magnesium may improve sleep quality, which is frequently disrupted in POTS.

Compression Garments [Grade B]

Compression garments counteract the venous pooling that drives POTS symptoms. But location and pressure matter more than most patients realize.

The Evidence

Studies demonstrate that waist-high compression stockings (30-40 mmHg) significantly reduce orthostatic heart rate increase and symptom severity in POTS. Abdominal compression binders provide additional benefit by reducing splanchnic (abdominal organ) blood pooling. Knee-high compression stockings, the type most commonly purchased, provide minimal benefit because most blood pools above the knee.

Protocol

Minimum: Waist-high compression stockings, 30-40 mmHg. Prescription-grade.

Ideal combination: Waist-high stockings plus an abdominal compression binder, particularly for use during upright activity.

Practical tip: Put compression garments on before getting out of bed in the morning, when blood has not yet pooled in the lower extremities. Donning them after symptoms have already started provides less benefit.

Iron [Grade B for Deficiency]

Low iron stores worsen POTS through a mechanism that most patients and many clinicians overlook.

The Evidence

Ferritin levels below 50 ng/mL are associated with worsened POTS symptoms. Low iron reduces the blood's oxygen-carrying capacity and impairs red blood cell production, both of which contribute to the hypovolemia that drives POTS pathophysiology. The standard "normal" ferritin range starts at 12-15 ng/mL, but POTS specialists target 70-100 ng/mL for optimal symptom control.

Protocol

Test first: Serum ferritin, iron, TIBC, and transferrin saturation. Do not supplement iron without confirming deficiency.

If ferritin is below 50: Iron bisglycinate 25-50mg every other day (better absorbed and less constipating than ferrous sulfate). Take with vitamin C and away from coffee, tea, and calcium.

If ferritin is below 20 or symptoms are severe: Discuss IV iron infusion with your provider. Oral repletion can take 3-6 months at this level.

B Vitamins: Thiamine and B12 [Grade B-C]

Two B vitamins have specific relevance to POTS, particularly the neuropathic subtype.

Thiamine (B1) [Grade C]

Case series have documented improvement in small fiber neuropathy symptoms with high-dose thiamine supplementation. Small fiber neuropathy is the structural damage that underlies neuropathic POTS, and thiamine deficiency impairs nerve function through reduced ATP production. The evidence base is limited to case series and clinical observation, hence the Grade C rating.

Dose: 100-300mg thiamine HCl daily, or 50-100mg benfotiamine (fat-soluble form with superior nerve penetration).

Vitamin B12 [Grade B-C]

B12 deficiency exacerbates autonomic neuropathy through impaired myelin synthesis. Metformin use, vegetarian diets, and pernicious anemia all increase B12 deficiency risk.

Test: Serum B12 and methylmalonic acid (MMA is more sensitive). Supplement if deficient: Methylcobalamin 1,000-5,000 mcg sublingual daily.

CoQ10 [Grade C]

Coenzyme Q10 supports mitochondrial energy production, and mitochondrial dysfunction has been proposed as a contributing factor in POTS-related fatigue and exercise intolerance.

The Evidence

No POTS-specific RCTs exist for CoQ10. The rationale is mechanism-based: CoQ10 is essential for the electron transport chain in mitochondria, and POTS patients frequently demonstrate exercise intolerance out of proportion to their cardiovascular fitness, suggesting an energy production deficit. CoQ10 supplementation improves exercise capacity and reduces fatigue in other populations with mitochondrial involvement (heart failure, statin myopathy, fibromyalgia).

Protocol

Dose: 200-300mg daily in divided doses.

Form: Ubiquinol is better absorbed than ubiquinone, particularly in patients over 40.

Timeline: Allow 4-8 weeks for subjective assessment.

Vagal Nerve Stimulation [Grade C]

The vagus nerve is the primary parasympathetic conduit between the brain and the cardiovascular, digestive, and immune systems. Vagal dysfunction is a documented feature of POTS, and restoring vagal tone is a logical therapeutic target.

The Evidence

Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive approach that stimulates the auricular branch of the vagus nerve through an ear clip. An RCT in long-COVID patients demonstrated reduced CRP (C-reactive protein) levels with taVNS, indicating measurable anti-inflammatory effects. The mechanism involves resetting the autonomic balance between sympathetic overdrive and parasympathetic withdrawal.

The POTS-specific evidence remains limited. Grade C reflects promising mechanistic rationale and early clinical signals without definitive POTS RCTs.

Protocol

Devices: gammaCore (prescription device for vagus nerve stimulation) and Xen by Neuvana (consumer auricular stimulator) are the two most commonly used options.

Duration: Typical protocols use 15-30 minute sessions, one to two times daily.

Best candidates: Patients with autoimmune or post-COVID POTS where neuroinflammation and autonomic dysregulation are prominent features.

Low-Dose Naltrexone for POTS [Grade C]

LDN has emerged as an intervention of particular interest for autoimmune and post-COVID POTS, addressing the neuroinflammatory component that salt and exercise cannot reach.

The Evidence

Isman and colleagues published an open-label study with 36 long-COVID subjects, many of whom had POTS. The study documented significant improvement in quality of life measured by SF-36, with approximately 50% of participants classified as clinical responders. A review in Frontiers in Cellular and Infection Microbiology (2025) catalogued emerging immunotherapies for POTS and identified LDN as a promising low-risk option warranting controlled trials.

The mechanism operates through transient opioid receptor blockade during the nighttime hours, which triggers a compensatory upregulation of endogenous endorphins and enkephalins. This modulates microglial activation (reducing neuroinflammation) and rebalances immune function. For a comprehensive breakdown, see our LDN for autoimmune conditions guide.

Who Should Consider LDN

LDN is best suited for POTS patients with autoimmune markers (anti-adrenergic antibodies, ANA positivity, or known autoimmune comorbidities) or post-COVID onset. It is less likely to benefit patients whose POTS stems from pure deconditioning without an immune component.

Protocol

Dose: Start 1.5mg nightly. Titrate by 0.5mg every one to two weeks to a target of 3-4.5mg.

Pharmacy: Compounding pharmacy required. LDN is not available as a standard commercial preparation.

Timeline: 8-12 weeks at target dose before assessing response. LDN is prescription-only; discuss with your provider.

Lifestyle Interventions That Cost Nothing

Supplements and exercise get the attention, but several zero-cost strategies produce meaningful symptom reduction.

Elevate the head of your bed 4 to 6 inches. This prevents overnight fluid redistribution to the kidneys and maintains higher blood volume upon waking. Use bed risers or a foam wedge under the mattress. Pillows alone are insufficient because they flex the neck without tilting the body.

Eat small frequent meals. Large meals divert blood to the splanchnic circulation for digestion, worsening orthostatic symptoms. Four to six smaller meals per day produce less postprandial blood pooling than three standard meals.

Avoid heat exposure. Hot showers, saunas, and hot weather cause vasodilation that directly worsens POTS. Use lukewarm water. If you live in a hot climate, prioritize morning and evening outdoor activity.

Counter-maneuvers when symptomatic. Crossing your legs while standing, flexing your calves, shifting weight from foot to foot, and squatting all activate the skeletal muscle pump and can abort pre-syncopal episodes. Keep a portable stool available for situations where prolonged standing is unavoidable.

What to Avoid

Excess caffeine. Small amounts may help vasoconstriction in some patients. But large doses increase heart rate, promote diuresis (counteracting fluid loading), and worsen the jittery, hyperadrenergic quality of POTS symptoms. If you use caffeine, keep it to one small coffee in the morning and monitor your response.

Alcohol. Vasodilator, dehydrating, and directly worsens orthostatic intolerance. Even one drink can trigger a symptom flare in sensitive patients.

Prolonged standing without movement. Standing still is worse than walking. The skeletal muscle pump activates during movement and deactivates when you stand motionless. If you must stand in line or at a counter, shift weight continuously.

Sedating antihistamines. Some POTS patients have overlapping mast cell activation syndrome (MCAS) and benefit from non-sedating antihistamines (cetirizine, fexofenadine). Sedating antihistamines like diphenhydramine worsen orthostatic symptoms and cognitive function. If MCAS is suspected, discuss targeted treatment with your provider rather than self-medicating.

Your POTS Protocol: Where to Start

Building an effective POTS protocol requires layering interventions systematically rather than implementing everything at once. The phased approach below mirrors what POTS specialty centers recommend.

Phase 1: Foundation (Weeks 1-4)

Begin with the interventions that have the strongest evidence and address the most fundamental mechanisms.

• Salt loading: Start at 3g sodium daily, titrate to 5-8g based on symptoms and blood pressure
• Fluid intake: 2-3 liters daily, always paired with electrolytes
• Electrolyte drink: 2-3 servings daily (LMNT, Vitassium, or equivalent)
• Magnesium: 125mg BID, advance to 250mg BID by week 3
• Compression garments: Waist-high 30-40 mmHg, donned before getting out of bed
• Lab testing: Ferritin, B12, vitamin D, basic metabolic panel, thyroid panel
• Bed elevation: Head of bed raised 4-6 inches

Phase 2: Exercise and Targeted Supplements (Weeks 3-8)

Once the foundation is stable, add exercise reconditioning and address any identified deficiencies.

• Begin CHOP or Dallas recumbent exercise protocol: 3-4 sessions/week, 25-30 minutes, recumbent only
• Iron supplementation: If ferritin is below 50 ng/mL, start iron bisglycinate every other day
• B12: If deficient, methylcobalamin 1,000-5,000 mcg sublingual daily
• Thiamine: 100mg daily (particularly if neuropathic subtype)
• CoQ10: 200mg daily for fatigue and exercise intolerance
• Vitamin D3: 2,000-5,000 IU daily if levels below 40 ng/mL

Phase 3: Advanced Interventions (Week 8 and Beyond)

For patients with autoimmune or post-COVID POTS who have plateaued with Phase 1 and 2 interventions.

• Discuss LDN with your provider: 1.5-4.5mg nightly, compounding pharmacy required
• Consider vagal nerve stimulation: taVNS devices for autonomic rebalancing
• Autoimmune POTS panel: Anti-adrenergic and anti-muscarinic receptor antibodies
• Functional testing: If gut symptoms are present, consider comprehensive stool analysis
• Exercise progression: Gradually introduce upright exercise per protocol timeline

Evidence Summary

Frequently Asked Questions

What is the best natural treatment for POTS?

Salt and fluid loading (3-10g sodium daily) combined with graded recumbent exercise are the two interventions with the strongest evidence. The 2021 POTS Expert Consensus endorses both as first-line non-pharmacological therapy. In the Levine/Dallas structured exercise trial, 53% of participants no longer met POTS diagnostic criteria after 3 months. These two interventions address the core mechanisms of hypovolemia and cardiac deconditioning. Start with recumbent exercises like rowing, swimming, or recumbent cycling and progress to upright activity only after 8 weeks.

Is POTS an autoimmune disease?

In a significant subset of patients, yes. Researchers have identified autoantibodies against adrenergic and muscarinic G-protein coupled receptors in POTS patients, which directly interfere with autonomic cardiovascular regulation. Post-COVID POTS appears especially driven by autoimmune mechanisms including molecular mimicry and vagal nerve injury. POTS also frequently co-occurs with established autoimmune conditions like Hashimoto's thyroiditis and Sjogren's syndrome. Autoimmune POTS may respond to different strategies than deconditioning-related POTS, making subtype identification clinically important.

How much salt do POTS patients need?

The 2021 POTS Expert Consensus recommends 3 to 10 grams of sodium daily, roughly two to four times the amount most people consume. Start at 3g and titrate upward over several weeks based on symptom response. Monitor blood pressure, especially if you have the hyperadrenergic subtype. Salt tablets (Vitassium, SaltStick) provide measured doses for accurate tracking. Patients with heart failure or uncontrolled hypertension should not increase sodium without cardiology supervision.

What supplements help POTS syndrome?

Magnesium (250-500mg twice daily) addresses rapid heart rate and vascular tone. Balanced electrolytes outperform sodium alone. Iron supplementation targets ferritin to 70-100 ng/mL in deficient patients, correcting hypovolemia at the cellular level. B1 (thiamine) supports small fiber nerve function. CoQ10 may improve the fatigue and exercise intolerance that limit rehabilitation. For autoimmune or post-COVID POTS, LDN shows promise based on the Isman et al. open-label study. See our supplements for autoimmune disease guide for broader context.

Does exercise help or worsen POTS?

Both. The outcome depends entirely on the approach. Intense upright exercise triggers symptom crashes and discourages patients from continuing. But a structured recumbent-first protocol that starts with swimming, rowing, or recumbent cycling and gradually introduces upright activity over 12 weeks is one of the most effective treatments available. The Levine study demonstrated increased cardiac mass, expanded blood volume, and improved autonomic regulation. The key principle: earn the right to stand up during exercise. Start horizontal and stay there for at least 8 weeks.

Can POTS be cured naturally?

Some patients achieve complete remission. Post-viral POTS has the highest remission rate, with many patients recovering within 1 to 3 years as the immune activation resolves. The Levine exercise study showed 53% of participants no longer met POTS criteria after just 3 months. Autoimmune POTS tends to follow a more chronic course but can still improve substantially with the interventions outlined in this guide. The combination of volume expansion, exercise reconditioning, and addressing any autoimmune component provides the best chance of long-term improvement.

Take the Next Step

POTS presents differently in every patient. Your subtype, trigger, severity, and comorbidities all shape which interventions will make the greatest difference.

Take the free AutoimmuneFinder quiz to receive a personalized evidence-graded protocol recommendation based on your specific situation. The quiz takes about 3 minutes and covers your symptoms, current treatments, and health priorities.

This article is for educational purposes only and does not constitute medical advice. POTS diagnosis requires proper medical workup including a tilt table test or active standing test. Always consult your cardiologist or autonomic specialist before starting any new supplement, exercise, or treatment protocol. Salt loading is contraindicated in patients with heart failure or uncontrolled hypertension. LDN requires a prescription from a licensed provider. Do not discontinue prescribed medications without medical guidance.